Both in Pharmaceuticals
Oncolytics Biotech vs Heron Therapeutics
Over the past year ONCY returned −63.8% and HRTX returned −74.0%; their daily moves had a correlation of 0.08.
ONCY −63.8% HRTX −74.0%Growth of $1, one year, split-adjusted
| Metric | ONCY | HRTX |
|---|---|---|
| Price | $0.4416 | $0.3089 |
| Market cap | $57.9M | $58.6M |
| Today | −4.48% | +2.45% |
| 1 month | −34.5% | +0.9% |
| 6 months | −49.3% | −74.0% |
| Year to date | −49.5% | −76.2% |
| 1 year | −63.5% | −73.8% |
| Revenue growth (YoY) | — | +1.3% |
| Gross margin | — | 69.3% |
| Net margin | — | −14.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.4× |
| Net cash | $4.1M | -$100.0M |
| Dividend yield | — | — |
| Volatility (60d) | 63.6% | 115.0% |
| Short % of float | 7.4% | 25.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).